We are live on
!
Find out more
TD Asset Management Portfolio holdings
AUM
$123B
1-Year Est. Return
34.51%
This Fund
S&P 500
This Quarter
Est. Return
+8.84%
1 Year Est. Return
+34.51%
3 Year Est. Return
+98.94%
5 Year Est. Return
+122.3%
10 Year Est. Return
+375.56%
AUM
$82.9B
AUM Growth
+$1.82B
(+2.3%)
Cap. Flow
-$3.2B
Cap. Flow
% of AUM
-3.86%
Top 10 Holdings %
Top 10 Hldgs %
27.48%
Holding
1,503
New
58
Increased
633
Reduced
567
Closed
76
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$256M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$156M |
| 4 |
Franco-Nevada
FNV
|
+$115M |
| 5 |
NVIDIA
NVDA
|
+$115M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Canadian Pacific Kansas City
CP
|
+$990M |
| 2 |
Pfizer
PFE
|
+$226M |
| 3 |
Amazon
AMZN
|
+$224M |
| 4 |
Johnson & Johnson
JNJ
|
+$220M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$220M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.76% |
| 2 | Financials | 19.43% |
| 3 | Healthcare | 10.94% |
| 4 | Consumer Discretionary | 8.03% |
| 5 | Communication Services | 7.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Baxter International
BAX
$14.5B
| $27.3M | 0.03% |
672,397
+23,516
| +4% | +$997K |
|
377
Keurig Dr Pepper
KDP
$42.1B
| $27.1M | 0.03% |
768,120
+131,635
| +21% | +$4.63M |
|
378
Archer Daniels Midland
ADM
$37.6B
| $26.7M | 0.03% |
335,128
+27,510
| +9% | +$2.25M |
|
379
Evergy
EVRG
$19.2B
| $26.7M | 0.03% |
436,577
+27,761
| +7% | +$1.69M |
|
380
B2Gold
BTG
$5.13B
| $26.6M | 0.03% |
6,729,132
-610,621
| -8% | -$2.27M |
|
|
MRO
381
DELISTED
Marathon Oil Corporation
MRO
| $26.5M | 0.03% |
1,107,797
+51,458
| +5% | +$1.32M |
|
382
RPM International
RPM
$14.2B
| $26.5M | 0.03% |
303,696
-13,888
| -4% | -$1.22M |
|
383
NVR
NVR
$16.6B
| $26.4M | 0.03% |
4,740
+1,425
| +43% | +$7.35M |
|
384
Idexx Laboratories
IDXX
$44.8B
| $26.4M | 0.03% |
52,745
+516
| +1% | +$247K |
|
385
Devon Energy
DVN
$51.4B
| $26.3M | 0.03% |
519,470
+5,549
| +1% | +$316K |
|
386
Illumina
ILMN
$29.9B
| $26.3M | 0.03% |
116,190
-5,784
| -5% | -$1.18M |
|
387
Cognex
CGNX
$11.2B
| $26.1M | 0.03% |
526,523
-20,954
| -4% | -$1.06M |
|
388
Target
TGT
$67.8B
| $26M | 0.03% |
157,273
-71,230
| -31% | -$11.7M |
|
389
Logitech
LOGI
$15.1B
| $26M | 0.03% |
447,113
-30,692
| -6% | -$1.74M |
|
390
ICU Medical
ICUI
$4.32B
| $25.8M | 0.03% |
156,176
-2,900
| -2% | -$499K |
|
391
NMI Holdings
NMIH
$3.35B
| $25.7M | 0.03% |
1,153,036
-24,955
| -2% | -$559K |
|
392
Marathon Petroleum
MPC
$89.6B
| $25.6M | 0.03% |
190,013
-9,605
| -5% | -$1.2M |
|
393
Brookfield Infrastructure
BIPC
$4.97B
| $25.6M | 0.03% |
555,871
+20,660
| +4% | +$900K |
|
394
Dow Inc
DOW
$21.6B
| $25.6M | 0.03% |
466,210
+418
| +0.1% | +$23.5K |
|
|
KRTX
395
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $25.4M | 0.03% |
139,935
+39,254
| +39% | +$7.51M |
|
396
Southern Company
SO
$107B
| $25.4M | 0.03% |
364,909
+4,333
| +1% | +$292K |
|
397
Ascendis Pharma A/S
ASND
$16B
| $25.3M | 0.03% |
236,194
+39,894
| +20% | +$4.56M |
|
398
Palo Alto Networks
PANW
$283B
| $25.3M | 0.03% |
253,328
+14,890
| +6% | +$1.26M |
|
399
Olin
OLN
$2.12B
| $25.3M | 0.03% |
455,577
+117,899
| +35% | +$6.75M |
|
400
Centene
CNC
$31.5B
| $25.2M | 0.03% |
398,135
-110,045
| -22% | -$7.81M |
|
Similar funds
VAM
TD Asset Management's Q1 2023 Portfolio in Review
As of Q1 2023, TD Asset Management held 1,503 positions worth $82.9B, up 2.3% from $81B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
TD Asset Management withdrew a net $3.2B in Q1 2023, closing 76 positions and reducing 567 holdings. Its most notable exit was Canadian Pacific Kansas City, an estimated $990M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
Against the trend, TD Asset Management opened a new position in Novo Nordisk worth $25.2M.
- TD Asset Management's largest Q1 2023 buy was Novo Nordisk: 316,140 shares worth $25.2M.
- TD Asset Management added most to Merck in Q1 2023, an estimated $256M increase.
- TD Asset Management's biggest Q1 2023 reduction was Pfizer, cutting an estimated $226M.
- TD Asset Management fully exited Canadian Pacific Kansas City in Q1 2023, selling an estimated $990M.
- TD Asset Management's ten largest holdings make up 27% of its $82.9B portfolio in Q1 2023.
- TD Asset Management opened 58 new positions and closed 76 in Q1 2023.
- TD Asset Management's portfolio value rose 2.3% quarter-over-quarter to $82.9B.
Based on TD Asset Management's 13F filing for Q1 2023, filed 10 May 2023.